miR-142:血液恶性瘤和治疗机会中的主调节剂
Wilson Huang1, Doru Paul2, George A Calin1,3,4
1Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cells
|January 11, 2024
概括
微RNAs (miRNAs),特别是miR-142,在血液细胞发育中起着至关重要的作用,并与血液癌症有关. 研究探讨了miR-142的研究.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 微RNA (miRNA) 是基因表达的关键调节者,它们的失调与癌症发展有关.
- miR-142高度保守,在造血细胞中表达,并与淋巴瘤和白血病相关.
研究的目的:
- 审查miR-142在生理学和血液形成中的多样性作用.
- 探索miR-142在外体介导运输中的参与.
- 为了分析miR-142基因组位点,突变和血液恶性瘤中的失调.
- 讨论针对血液癌症的miR-142治疗策略.
主要方法:
- 文献综述和对miR-142现有研究的综合.
- 分析与miR-142位点相关的遗传和分子数据.
- 探索外体介导的miRNA运输机制.
主要成果:
- miR-142显著影响血液构成和血液构成细胞功能.
- 在各种血液性恶性瘤中观察到miR-142的失调和突变.
- 外基因组在miR-142.2的细胞间传输中发挥作用.
结论:
- miR-142是正常血液形成和血液癌症的发病的一个关键因素.
- 了解miR-142的功能和失调,可以了解血液癌症的潜在治疗点.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


